Monocentric evaluation of the Novaplex dermatophyte multiplex qPCR assay in the diagnosis of dermatophytoses
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.00894-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Florian Harel und 3 weiteren Autor:innen. Beteiligte Einrichtung: CHU Rennes, Laboratoire de parasitologie-mycologie, European ECMM Excellence Center in Medical Mycology, Centre National de Référence pour les mycose…. Hauptthemen laut MEDLINE: Multiplex Polymerase Chain Reaction, Sensitivity and Specificity, Arthrodermataceae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Superficial fungal infections caused by dermatophytes are a prevalent global health concern. Rapid and accurate diagnosis of these pathogens through molecular tools would offer a substantial advantage for early detection and effective treatment. The conventional fungal culture presents inherent limitations, including extended result delivery delay and variable sensitivity. This study aimed to evaluate the performance of the multiplex real-time PCR Novaplex dermatophyte assay (Seegene) in comparison to traditional mycological methods including direct examination and culture. A total of 312 nail, skin, and scalp samples collected from patients with suspected superficial fungal infections for mycological diagnosis were retrospectively subjected to the Novaplex dermatophyte assay. Overall, 170 (54.6%) and 186 (59.6%) samples tested positive for dermatophyte culture and dermatophyte PCR, respectively. The concordance between PCR and culture for dermatophyte detection was 87.2%. There were 158 culture-positive/PCR-positive samples, 12 culture-positive/PCR-negative samples, and 28 culture-negative/PCR-positive samples. The sensitivity of PCR against culture varied according to the dermatophyte target, ranging from 90.5% ( Trichophyton mentagrophytes/interdigitale/benhamiae ), 91.2% ( Trichophyton rubrum ), to 100% ( Microsporum spp. and Trichophyton tonsurans ). When considering the final diagnosis using composite criteria, the sensitivity and specificity for the diagnosis of dermatophytosis were 92.9% and 96.6% for PCR, 86.7% and 100% for culture, and 95.4% and 92.2% for direct examination and culture combined, respectively. The Seegene Novaplex dermatophyte assay is an easy-to-use automated one-step extraction-PCR system that offers satisfactory performance for routine diagnosis of dermatophytoses in clinical laboratories, particularly in non-specialized centers. However, it cannot fully replace conventional mycology due to its inability to detect mold infections and to identify dermatophytes at the species level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHU Rennes, Laboratoire de parasitologie-mycologie, European ECMM Excellence Center in Medical Mycology, Centre National de Référence pour les mycoses et antifongiques-Laboratoire associé Aspergilloses chroniques, Renne…
- Univ Rennes, CHU Rennes, Inserm, Irset (Institut de recherche en santé, environnement et travail), Rennes, France.
ORCID-Profile: Florence Robert-Gangneux, Jean-Pierre Gangneux, Hélène Guegan
Zitieren
APA
Harel, F., Robert-Gangneux, F., Gangneux, J. P., & Guegan, H. (2024). Monocentric evaluation of the Novaplex dermatophyte multiplex qPCR assay in the diagnosis of dermatophytoses. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00894-24
Vancouver
Harel F, Robert-Gangneux F, Gangneux JP, Guegan H. Monocentric evaluation of the Novaplex dermatophyte multiplex qPCR assay in the diagnosis of dermatophytoses. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00894-24
BibTeX
@article{Harel2024,
author = {Harel, Florian and Robert-Gangneux, Florence and Gangneux, Jean-Pierre and Guegan, Hélène},
title = {Monocentric evaluation of the Novaplex dermatophyte multiplex qPCR assay in the diagnosis of dermatophytoses},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.00894-24}
}
EUVIMED